Philip Morris's Zyn is experiencing explosive growth, with US shipments up 53% and international volumes up 182% year-over-year. PM beat earnings estimates last week and raised guidance after crushing analyst forecasts. The company is in the process of building a massive Zyn factory in Colorado to meet soaring demand, positioning itself for significant future earnings growth.

I rate Texas Instruments as a hold due to balanced risk-reward, margin pressures, elevated inventory levels, and tariff uncertainties clouding the medium-term outlook. TXN's 1Q25 results showed revenue growth and signs of recovery, but gross margins and elevated inventory levels remain concerns. Despite revenue improvements, margin pressures from higher manufacturing costs and tariff uncertainties in China pose significant risks to TXN's profitability.

NEW YORK , April 29, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Napco Security Technologies, Inc. ("Napco" or the "Company") (NASDAQ: NSSC) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Napco investors who were adversely affected by alleged securities fraud between February 5, 2024 and February 3, 2025.

NEW YORK , April 29, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Cerevel Therapeutics Holdings, Inc. ("Cerevel Therapeutics Holdings, Inc." or the "Company") (NYSE: ABBV) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Cerevel Therapeutics Holdings, Inc. investors who were adversely affected by alleged securities fraud.

NEW YORK , April 29, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in NET Power, Inc. ("NET Power, Inc." or the "Company") (NYSE: NPWR) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of NET Power, Inc. investors who were adversely affected by alleged securities fraud between June 9, 2023 and March 7, 2025.

NEW YORK , April 29, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Zenas BioPharma, Inc. ("Zenas BioPharma, Inc." or the "Company") (NASDAQ: ZBIO) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Zenas BioPharma, Inc. investors who were adversely affected by alleged securities fraud.

NEW YORK , April 29, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Treace Medical Concepts, Inc. ("Treace Medical Concepts, Inc." or the "Company") (NASDAQ: TMCI) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Treace Medical Concepts, Inc. investors who were adversely affected by alleged securities fraud between May 8, 2023 and May 7, 2024.

NEW YORK , April 29, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in BigBear.ai Holdings, Inc. ("BigBear.ai Holdings" or the "Company") (NYSE: BBAI) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of BigBear.ai Holdings investors who were adversely affected by alleged securities fraud between March 31, 2022 and March 25, 2025.

$19.3 million. That's how much money you'd have today if you bought $10,000 worth of Amazon (AMZN -0.59%) shares at its IPO in 1997 and never sold.

NEW YORK , April 29, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Viatris Inc. ("Viatris" or the "Company") (NASDAQ: VTRS) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Viatris investors who were adversely affected by alleged securities fraud between August 8, 2024 and February 26, 2025.

The market's starting to claw its way back up, but things are looking iffy, and they've been changing on a moment's notice.

Several former traders from oil major Shell have set up trading house Atmin, backed by Afreximbank, to focus on African oil trading, two trading sources familiar with the development said.

Artificial intelligence, or AI, is undeniably a massive opportunity with room for multiple big winners. Many of the most promising AI stocks have fallen out of favor recently thanks to economic uncertainty and AI spending concerns.

“AI-diffusion” rules could limit the U.S. chip company's sales even to friendly countries—and give more opportunity to foreign rivals.

In today's video, I discuss Nvidia (NVDA -2.02%) and what its partners shared during recent earnings calls. To learn more, check out the short video, consider subscribing, and click the special offer link below.

The Delaware facility will ensure a domestic supply of biologic drugs including the cancer drug Keytruda.

Snap (SNAP 3.92%) will deliver key insights to shareholders on April 29 that investors will not want to miss.

The S&P 500 is making a slow rebound from its tariff-induced plunge a few weeks ago, and it's now down 6% year to date.

While there are some ways semiconductor giant Intel (INTC 2.37%) could benefit from the Trump administration's tariff policies and push to bring manufacturing back to the United States, the company is unlikely to be a trade war winner. Economic uncertainty could push down demand for PCs and lead data center operators to pull back on capital spending, bad news for Intel's core CPU business.

The upcoming earnings of AMD will be crucial for the company in terms of forward guidance on AI revenue trajectory and the impact of tariffs. We could see AMD beat estimates for first quarter similar to Intel due to customers pulling ahead their purchases to prevent a tariff hit. AMD has stopped giving guidance for AI revenue, but the product pipeline is strong, and the company could still reach over $10 billion in AI revenue in 2025.